Summary
The effects of 5-hydroxytryptamine and 5-hydroxytryptophan on insulin release and 45Ca2+ uptake in islets microdissected from ob/ob mice were studied. At a concentration of 4 mmol/l both compounds slightly stimulated insulin release at a low glucose concentration (3 mmol/l). Insulin release induced by 20 mmol/l D-glucose was inhibited by 4 mmol/l 5-hydroxytryptamine but potentiated by 4 mmol/l L-5-hydroxytryptophan. Mannoheptulose (20 mmol/l) blocked the combined effects of 20 mmol/l D-glucose and 4 mmol/l L-5-hydroxytryptophan on insulin release. 45Ca2+ uptake was inhibited by 4 mmol/l 5-hydroxytryptamine and stimulated by 4 mmol/l L-5-hydroxytryptophan. Mannoheptulose (20 mmol/l) did not affect the 45Ca2+ uptake induced by the latter. When 4 mmol/l L-5-hydroxytryptophan was present only during the 30-min preincubation period, 20 mmol/l-glucose-induced insulin release and 45Ca2+ uptake during a subsequent incubation period were inhibited. Externally added 5-hydroxytryptamine (4 mmol/l) did not change the effects of 4 mmol/l L-5-hydroxytryptophan on insulin release and 45Ca2+ uptake. It is concluded that, when added directly into the incubation medium, 5-hydroxytryptophan has effects on insulin release and 45Ca2+ uptake which are opposite to those observed when 5-hydroxytryptamine is added. These effects do not seem to be mediated by 5-hydroxytryptamine formed intracellularly from 5-hydroxytryptophan.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cegrell L, Falck B, Hellman B (1964) Monoaminergic mechanisms in the endocrine pancreas. In: Brolin SE, Hellman B, Knutson H (eds) The structure and metabolism of the pancreatic islets. Pergamon Press, Oxford, pp 429–435
De Leiva A, Tanenberg RJ, Anderson G, Greenberg B, Senske B, Goetz FC (1978) Serotoninergic activation and inhibition: effects on carbohydrate tolerance and plasma insulin and glucagon. Metabolism 27: 511–520
Gagliardino JJ, Nierle C, Pfeiffer EF (1974) The effect of serotonin on in vitro insulin secretion and biosynthesis in mice. Diabetologia 10: 411–414
Lebovitz HE, Feldman JM (1973) Pancreatic biogenic amines and insulin secretion in health and disease. Federation Proc 32: 1797–1802
Lundquist I, Ekholm R, Ericson LE (1971) Monoamines in the pancreatic islets of the mouse. 5-Hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycemic action of monoamine oxidase inhibitors. Diabetologia 7: 414–422
Cegrell L (1970) Monoaminergic mechanisms in the pancreatic α-cells. In: Falkmer S, Hellman B, Täljedal I-B (eds) Structure and function of the pancreatic islets. Pergamon Press, Oxford, pp 131–140
Feldman JM (1979) Species variation in the islets of Langerhans. Diabetologia 16: 1–4
Jacoby JH, Bryce GF (1978) Monoaminergic modulation of pancreatic endocrine secretion. Gen Pharmacol 9: 411–419
Lebovitz HE (1979) Serotoninergic regulation of metabolism. In: Essman WB (ed) Serotonin in health and disease, vol 5. Spectrum Publications, New York, pp 213–263
Smith PH, Porte Jr D (1976) Neuropharmacology of the pancreatic islets. Ann Rev Pharmacol Toxicol 16: 269–285
Sundler F, Håkanson R, Lorén I, Lundquist I (1980) Amine storage and function in peptide hormone-producing cells. Invest Cell Pathol 3: 87–103
Cegrell L (1968) The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Physiol Scand, Suppl 314: 1–60
Ekholm R, Ericson LE, Lundquist I (1971) Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia 7: 339–348
Gylfe E, Hellman B, Sehlin J, Täljedal I-B (1973) Amino acid conversion into 5-hydroxytryptamine in pancreatic β-cells. Endocrinology 93: 932–937
Hellman B, Lernmark Å, Sehlin J, Täljedal I-B (1972) Transport and storage of 5-hydroxytryptamine in pancreatic β-cells. Biochem Pharmacol 21: 695–706
Lindström P (1981) Further studies on 5-hydroxytryptamine transport in pancreatic islets and isolated β-cells. Br J Pharmac 73: 385–391
Lindström P, Sehlin J, Täljedal I-B (1980) Characteristics of 5-hydroxytryptamine transport in pancreatic islets. Br J Pharmac 68: 773–778
Mahoney C, Feldman JM (1977) Species variation in pancreatic islet monoamine uptake and action. Diabetes 26: 257–261
Feldman JM, Lebovitz HE (1970) Specificity of serotonin inhibition of insulin release from golden hamster pancreas. Diabetes 19: 475–479
Feldman JM, Lebovitz HE (1972) A Serotoninergic mechanism for the control of insulin secretion. Trans Assoc Am Physicians 85: 279–294
Pontiroli AE, Micossi P, Foà PP (1978) Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas. Horm Metab Res 10: 200–203
Wollheim CB, Sharp GWG (1981) Regulation of insulin release by calcium. Physiological Reviews 61: 914–973
Hellerström C (1964) A method for the microdissection of intact pancreatic islets of mammals. Acta Endocrinol (Kbh) 45: 122–132
Hellman B (1965) Studies in obese-hyperglycemic mice. Ann NY Acad Sci 131: 541–558
Hellman B, Idahl L-Å, Lernmark Å, Sehlin J, Simon E, Täljedal I-B (1972) The pancreatic β-cell recognition of insulin secretagogues. I. Transport of mannoheptulose and the dynamics of insulin release. Mol Pharmacol 8: 1–7
De Luca HF, Cohen PP (1964) Suspending media for animal tissues. In: Umbreit WW, Burns RH, Stauffer JF (eds) Manometric techniques, 4th edn. Burgess Publishing Company, Minneapolis, pp 131–133
Hellman B, Sehlin J, Täljedal I-B (1976) Effects of glucose on 45Ca2+ uptake by pancreatic islets as studied with the lanthanum method. J Physiol (Lond) 254: 639–656
Tjälve H (1971) Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study. Acta Physiol Scand, Suppl 360: 1–122
Feldman JM, Lebovitz HE (1970) Serotonin inhibition of in vitro insulin release from golden hamster pancreas. Endocrinology 86: 66–70
Gagliardino JJ, Zieher LM, Iturriza FC, Hernández RE, Rodríguez RR (1971) Insulin release and glucose changes induced by serotonin. Horm Metab Res 3: 145–150
Lechin F, Coll-García E, Van Der Dijs B, Pena F, Bentolila A, Rivas C (1975) The effect of serotonin (5-HT) on insulin secretion. Acta Physiol Lat Am 25: 339–346
Quickel Jr KE, Feldman JM, Lebovitz HE (1971) Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology 89: 1295–1302
Tamarit J, Tamarit-Rodriguez J, Goberna R (1973) Changes in insulin secretion induced by serotonin. Diabetologia 9: 92
Telib M, Raptis S, Schröder KE, Pfeiffer EF (1968) Serotonin and insulin release in vitro. Diabetologia 4: 253–256
Lernmark Å (1971) The significance of 5-hydroxytryptamine for insulin secretion in the mouse. Horm Metab Res 3: 305–309
Federspil G, Casara D, Pedrazzoli S, Sicolo N, Scandellari C (1974) In vivo studies on 5-hydroxytryptamine and insulin secretion in dogs and in man. Diabetologia 10: 13–17
Furman BL, Wilson GA (1980) Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia 19: 386–390
Jacoby JH, Bryce GF (1978) The acute pharmacologic effects of serotonin on the release of insulin and glucagon in the intact rat. Arch Int Pharmacodyn Ther 235: 254–270
Jacoby JH, Bryce GF (1979) The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat. Horm Metab Res 11: 90–94
Lindström P, Sehlin J (1982) 5-Hydroxytryptamine stimulates 86Rb+ efflux from pancreatic β-cells. Biochim Biophys Acta 720: 400–404
Lindström P, Sehlin J (1982) Action of 5-hydroxytryptamine on the 36Cl− efflux in pancreatic β-cells. Acta Physiol Scand 116: 101–102
Lindström P (1981) 5-HT inhibits glucose-induced changes in fluxes of 86Rb+, 36Cl−, and 33Pi in pancreatic B-cells. Diabetologia 21: 297–298
Hellman B, Lenzen S, Sehlin J, Täljedal I-B (1977) Effects of various modifiers of insulin release on the lanthanum-nondisplaceable 45Ca2+ uptake by isolated pancreatic islets. Diabetologia 13: 49–53
Hellman B, Idahl L-Å, Lenzen S, Sehlin J, Täljedal I-B (1978) Further studies on the relationship between insulin and lanthanumnondisplaceable 45Ca2+ uptake by pancreatic islets: effects of fructose and starvation. Endocrinology 102: 1856–1863
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindström, P., Sehlin, J. Opposite effects of 5-hydroxytryptophan and 5-hydroxytryptamine on the function of microdissected ob/ob-mouse pancreatic islets. Diabetologia 24, 52–57 (1983). https://doi.org/10.1007/BF00275948
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00275948